These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1279826)

  • 1. [The clinico-laboratory dynamics in the reaferon treatment of glomerulonephritis patients with the nephrotic syndrome].
    Shishkin AN; Sosunov AV; Romanova VI; Korneeva EP; Orlov VA
    Ter Arkh; 1992; 64(6):29-32. PubMed ID: 1279826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dynamic production of interferons, interleukins and arachidonic acid metabolites by the blood cells of children with glomerulonephritis associated with HB virus infection while treated with reaferon].
    Markarian AS; Malinovskaia VV; Dlin VV; Ignatov MS; Asratian AA; Pronin AV
    Vopr Virusol; 1993; 38(4):152-6. PubMed ID: 7694426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disordered interferon status in patients with urticaria and angioneurotic edema against a background of frequent ARVI: its correction with reaferon].
    Belostotskaia OI; Grigorian SS; Poroshina IuA; Ivanova LA; Gervazieva VB
    Vopr Virusol; 1989; 34(2):176-80. PubMed ID: 2474903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of the pathogenesis and clinical forms of the course of glomerulonephritis in adolescent patients].
    Dudar IO
    Lik Sprava; 1999; (3):115-8. PubMed ID: 10474954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reaferon in the treatment of hemorrhagic fever with the renal syndrome].
    Ivanov KS; Roshchupkin VI; Koshil' OI; Morozov VG; Utkin VN
    Antibiot Khimioter; 1994 Jan; 39(1):42-6. PubMed ID: 8060195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinico-laboratory effects of acupuncture in patients with glomerulonephritis].
    Holub TI
    Lik Sprava; 1999 Jun; (4):157-61. PubMed ID: 10476672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
    Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
    Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on glomerular disease in the elderly.
    Glassock RJ
    Clin Geriatr Med; 2013 Aug; 29(3):579-91. PubMed ID: 23849009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative analysis of the effect of alpha 2-interferon (reaferon) therapy on the morphofunctional state of the bone marrow in patients with chronic myeloleukemia].
    Abdulkadyrov KM; Rukavitsyn OA; Moiseev SI; Rugal' VI
    Gematol Transfuziol; 1993 Mar; 38(3):11-3. PubMed ID: 8020725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP
    J Nephrol; 1999; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
    Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
    Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The glomerulus in all its states].
    Grosch S; Erpicum P; Bouquegneau A; Jouret F; Bovy C
    Rev Med Liege; 2022 May; 77(5-6):330-337. PubMed ID: 35657191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor effect of the Soviet recombinant alpha2-interferon (reaferon) under experimental conditions].
    Lavrukhina LA; Posevaia TA; Barinskiĭ IF; Ershov FI
    Vopr Virusol; 1989; 34(3):312-5. PubMed ID: 2477953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Velychko MB; Dudar IO
    Lik Sprava; 1992 Oct; (10):52-4. PubMed ID: 1485447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of reaferon in treating patients with protracted viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Nazarenko IV
    Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrotic syndrome in primary glomerulonephritis].
    Riabov SI; Plotkin VIa; Klemina IK
    Ter Arkh; 1986; 58(8):65-71. PubMed ID: 3764764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B].
    Andreĭchin MA; Rudchik AS; Borak VF
    Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
    Kolesnik NA; Dudar' IA; Velichko MB
    Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare cause of nephrotic syndrome in a 14-year-old boy: questions.
    Nalcacioglu H; Tekcan D; Genc G; Comba A; Can Meydan B; Caltepe G; Ozkaya O; Kalayci AG
    Pediatr Nephrol; 2013 Jul; 28(7):1067, 1069-71. PubMed ID: 22918442
    [No Abstract]   [Full Text] [Related]  

  • 20. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration].
    Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL
    Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.